Both the activation of glycogen synthase kinase‐3β (GSK‐3β) and the presence of ApoE ε4 genotype have been found to respectively correlate with cognitive decline in patients with type 2 diabetes mellitus (T2DM), who further show a high incidence of developing Alzheimer's disease. Here, GSK3B is linked to diabetes mellitus.